(Q48395191)

11 February 2018

title

Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice (English)

1 reference

11 February 2018

1 reference

Yuki Kita

1

1 reference

11 February 2018

Yukio Ago

2

1 reference

11 February 2018

Erika Takano

3

1 reference

11 February 2018

Asako Fukada

4

1 reference

11 February 2018

Kazuhiro Takuma

5

1 reference

11 February 2018

Toshio Matsuda

6

1 reference

11 February 2018

publication date

30 August 2012

1 reference

11 February 2018

published in

Psychopharmacology

1 reference

11 February 2018

volume

225

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

543-551

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-012-2841-7

exact match

0 references

cites work

A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Pharmacological aspects of the acetylcholinesterase inhibitor galantamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Insulin-like growth factor-I and neurogenesis in the adult mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

The nicotinic acetylcholine receptor agonist (+/-)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Gene expression profiling of neural stem cells and their neuronal progeny reveals IGF2 as a regulator of adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

VEGF links hippocampal activity with neurogenesis, learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

IGF2: epigenetic regulation and role in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

A critical role for IGF-II in memory consolidation and enhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Placental-specific IGF-II is a major modulator of placental and fetal growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

The Allosteric Potentiation of Nicotinic Acetylcholine Receptors by Galantamine Is Transduced into Cellular Responses in Neurons: Ca2+Signals and Neurotransmitter Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Nerve growth factor promotes survival of new neurons in the adult hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Hormonal regulation of fetal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Alzheimer's disease drugs promote neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

The cerebrospinal fluid provides a proliferative niche for neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

An update on the pharmacology of galantamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity rela

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2841-7

Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor

21 January 2018

1 reference

12 December 2020

Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands

1 reference

12 December 2020

Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation

1 reference

12 December 2020

Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid

1 reference

12 December 2020

10.1007/S00213-012-2841-7

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018